(Q72426675)
Statements
Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC). A study of the National Cancer Institute of Canada Clinical Trials Group (English)
Y Cormier
E Eisenhauer
A Muldal
R Gregg
J Ayoub
G Goss
D Stewart
P Tarasoff
1 March 1994